Disseminated mediterranean kaposi sarcoma treated with low-dose recombinant interferon alfa-2a [1]

Journal of the American Academy of Dermatology

Volumn 48, Issue 1, 2003, Pages 148-149

  Rubegni, Pietro ^a   Cuccia, Aldo ^b   Sbano, Paolo ^b   Miracco, Clelia ^b   Pacenti, Lorenzo ^b   Fimiani, Michele ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON;

ADULT; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; KAPOSI SARCOMA; LETTER; MALE; PRIORITY JOURNAL; ULTRAVIOLET B RADIATION;

EID: 0037231617     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2003.31     Document Type: Letter

References (11)

1. Keméni L, Gyulai R, Kiss M, Nagy F, Dobozy A. Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8: a new virus in human pathology. J Am Acad Dermatol 1997;37:107-13.
2. Noel JC, Hermans P, Andre J, Fayt I, Simonart TH,Verhest A, et al. Herpesvirus-like DNA sequences and Kaposi's sarcoma: relationship with epidemiology, clinical spectrum, and histologic features. Cancer 1996;77:2132-6.
3. Monini P, Colombini S, Sturzl M, Goletti D, Cafaro A, Sgadari C, et al. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood 1999;93:4044-58.
4. Tebbe B, Mayer-da-Silva A, Garbe C, von Keyserlingk HJ, Orfanos CE. Genetically determined coincidence of Kaposi sarcoma and psoriasis in an HIV-negative patient after prednisolone treatment. Int J Dermatol 1991;30:114-20.
5. Woffer LU, Goerdt S, Schroder K, Zouboulis CC, Orfanos CE. Interferon-alpha-induced psoriasis vulgaris. Hautarzt 1996;47:124-8.
6. De Filippi C, Regazzini R, Sacchi S. Reflections on unexpected onset of Kaposi's sarcoma in a case of psoriasis. G Ital Dermatol Venereol 1990;125:579-81.
7. De Aloe G, Rubegni P, Pacenti L, Miracco C, Fimiani M. Human herpesvirus type 8 is not associated with pyogenic granulomas with satellite recurrence. Br J Dermatol 2001;144:202-3.
8. Lahiri DK, Nurberger JI Jr. A rapid non-enzymatic method for the preparation of HMV DNA from blood for RFLP studies. Nucleic Acids Res 1991;19:5444.
9. Costa da Cunha CS, Lebbe C, Rybojad M, Agbalika F, Ferchal F, Rabian C, et al. Long term follow-up of non-HIV Kaposi's sarcoma treated with low dose recombinant interferon-alpha-2b. Arch Dermatol 1996;132:285-90.
10. Downs AM, Dunnill MG. Exacerbation of psoriasis by interferon-alpha therapy for hepatitis C. Clin Exp Dermatol 2000;25:351-2.
11. Austin HL, Ozawa M, Kikuchi T, Walters IB, Krueger JG. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and the effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 1999;113:752-9.